Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Finasteride may improve prostate cancer treatment outcomes.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Finasteride side effects in young men may be linked to specific gene variations.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Tailored combination therapy improves non-scarring alopecia outcomes.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.